郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign.

期刊：International journal of molecular sciences发表年份：2020作者：Patricia Gomez-Gutierrez; Juan J Perez
阅读更多 →

药效评价VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease.

期刊：Inflammopharmacology发表年份：2020作者：Leo R Fitzpatrick; Jeff Small; Robert O'Connell; George Talbott; Gordon Alton; Jim Zapf
阅读更多 →

药效评价Long term multiple sclerosis drug delivery using dendritic polyglycerol flower-like microspheres.

期刊：Journal of biomaterials science. Polymer edition发表年份：2020作者：Priscila Veloso da Silva; Alvaro Antonio Alencar de Queiroz
阅读更多 →

药效评价Estimation of Process Model Parameters.

期刊：Methods in molecular biology (Clifton, N.J.)发表年份：2020作者：Sahar Deppe; Björn Frahm; Volker C Hass; Tanja Hernández Rodríguez; Kim B Kuchemüller; Johannes Möller; Ralf Pörtner
阅读更多 →